MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study

International Journal of Cancer

Volumn 131, Issue 3, 2012, Pages

  Cust, Anne E ^a,b   Goumas, Chris ^a   Holland, Elizabeth A ^c   Agha Hamilton, Chantelle ^c   Aitken, Joanne F ^d   Armstrong, Bruce K ^a   Giles, Graham G ^b,e   Kefford, Richard F ^c   Schmid, Helen ^c   Hopper, John L ^b   Mann, Graham J ^c   Jenkins, Mark A ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

early onset; MC1R; melanoma; nevi; phenotype; sun exposure

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

ADULT; AUSTRALIA; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCORTIN 1 RECEPTOR GENE; MELANOMA; NEVUS; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SIBLING; SUN EXPOSURE;

ADOLESCENT; ADULT; ALLELES; AUSTRALIA; BASE SEQUENCE; CASE-CONTROL STUDIES; FAMILY; FEMALE; GENES, REGULATOR; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MELANINS; MELANOMA; QUESTIONNAIRES; RECEPTOR, MELANOCORTIN, TYPE 1; RISK; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84861574698     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27357     Document Type: Review

References (32)

1. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C,. Melanocortin-1 receptor structure and functional regulation. Pigm Cell Res 2005; 18: 393-410.
2. Harding RM, Healy E, Ray AJ, Ellis NS, Flanagan N, Todd C, Dixon C, Sajantila A, Jackson IJ, Birch-Machin MA, Rees JL,. Evidence for variable selective pressures at MC1R. Am J Hum Genet 2000; 66: 1351-61.
3. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC,. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008; 122: 2753-60.
4. Kanetsky PA, Panossian S, Elder DE, Guerry D, Ming ME, Schuchter L, Rebbeck TR,. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 2010; 116: 2416-28.
5. Williams PF, Olsen CM, Hayward NK, Whiteman DC,. Melanocortin-1-receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 2011; 129: 1730-40.
6. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, Jackson IJ, Rees JL,. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996; 5: 1663-6.
7. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN,. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294-300.
8. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA,. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 176-86.
9. Han J, Kraft P, Colditz GA, Wong J, Hunter DJ,. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119: 1976-84.
10. Hayward NK,. Genetics of melanoma predisposition. Oncogene 2003; 22: 3053-62.
11. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR), Cancer in Australia: an overview, 2008. AIHW, 2008.
12. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, et al. SEER Cancer Statistics Review, 1975-2006 ed. Bethesda, MD. Available at:: National Cancer Institute, 2009.
13. Cancer Research UK. CancerStats - Cancer Statistics for the UK. Accessed 6 April 2011.
14. Cust AE, Schmid H, Maskiell JA, Jetann J, Ferguson M, Holland EA, Agha-Hamilton C, Jenkins MA, Kelly J, Kefford RF, Giles GG, Armstrong BK, et al. Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. Am J Epidemiol 2009; 170: 1541-54.
15. Cattley S, Arthur JW,. BioManager: the use of a bioinformatics web application as a teaching tool in undergraduate bioinformatics training. Brief Bioinform 2007; 8: 457-65.
16. Beaumont KA, Shekar SN, Newton RA, James MR, Stow JL, Duffy DL, Sturm RA,. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 2007; 16: 2249-60.
17. Flanagan N, Healy E, Ray A, Philips S, Todd C, Jackson IJ, Birch-Machin MA, Rees JL,. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000; 9: 2531-7.
18. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR, Hayward NK, Martin NG, Sturm RA,. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004; 13: 447-61.
19. Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR,. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev 2004; 13: 808-19.
20. Schioth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL,. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999; 260: 488-91.
21. Savage SA, Gerstenblith MR, Goldstein AM, Mirabello L, Fargnoli MC, Peris K, Landi MT,. Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet 2008; 9: 31.
22. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT,. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007; 28: 495-505.
23. Kricker A, Armstrong BK, Goumas C, Kanetsky P, Gallagher RP, Begg CB, Millikan RC, Dwyer T, Rosso S, Marrett LD, Thomas NE, Berwick M,. MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study. Cancer Causes Control 2010; 21: 2137-47.
24. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA,. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-6.
25. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006; 66: 9330-7.
26. Han J, Colditz GA, Hunter DJ,. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 2006; 35: 1514-21.
27. Galea S, Tracy M,. Participation rates in epidemiologic studies. Ann Epidemiol 2007; 17: 643-53.
28. Hopper JL, Bishop DT, Easton DF,. Population-based family studies in genetic epidemiology. Lancet 2005; 366: 1397-406.
29. Gauderman WJ, Witte JS, Thomas DC,. Family-based association studies. J Natl Cancer Inst Monogr 1999: 31-7.
30. Witte JS, Gauderman WJ, Thomas DC,. Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 1999; 149: 693-705.
31. Curtis D,. Use of siblings as controls in case-control association studies. Ann Hum Genet 1997; 61: 319-33.
32. Milne RL, John EM, Knight JA, Dite GS, Southey MC, Giles GG, Apicella C, West DW, Andrulis IL, Whittemore AS, Hopper JL,. The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry. Int J Epidemiol 2011; 40: 1342-54.